Braf V600e Clinical Trials

ReadTheTrial indexes 1 studies for Braf V600e. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Braf V600e.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
100%

Trial Status Breakdown

Trials for Braf V600e

A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal Cancer

NCT07506109 · RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Braf V600e?

There are 1 clinical trials listed for Braf V600e. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Braf V600e trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Braf V600e trials in?

Current Braf V600e trials are distributed across: Phase 2 (1).

Find More Trials